The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
Open accessAbstract
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious tentacles of the disease have been disseminated worldwide with unknown complications and repercussions. Advanced COVID-19 syndrome is characterized by the uncontrolled and elevated release of pro-inflammatory cytokines and suppressed immunity, leading to the cytokine storm. The uncontrolled and dysregulated secretion of inflammatory and pro-inflammatory cytokines is positively associated with the severity of the viral infection and mortality rate. The secretion of various pro-inflammatory cytokines such as TNF-α, IL-1, and IL-6 leads to a hyperinflammatory response by recruiting macrophages, T and B cells in the lung alveolar cells. Moreover, it has been hypothesized that immune cells such as macrophages recruit inflammatory monocytes in the alveolar cells and allow the production of large amounts of cytokines in the alveoli, leading to a hyperinflammatory response in severely ill patients with COVID-19. This cascade of events may lead to multiple organ failure, acute respiratory distress, or pneumonia. Although the disease has a higher survival rate than other chronic diseases, the incidence of complications in the geriatric population are considerably high, with more systemic complications. This review sheds light on the pivotal roles played by various inflammatory markers in COVID-19-related complications. Different molecular pathways, such as the activation of JAK and JAK/STAT signaling are crucial in the progression of cytokine storm; hence, various mechanisms, immunological pathways, and functions of cytokines and other inflammatory markers have been discussed. A thorough understanding of cytokines’ molecular pathways and their activation procedures will add more insight into understanding immunopathology and designing appropriate drugs, therapies, and control measures to counter COVID-19. Recently, anti-inflammatory drugs and several antiviral drugs have been reported as effective therapeutic drug candidates to control hypercytokinemia or cytokine storm. Hence, the present review also discussed prospective anti-inflammatory and relevant immunomodulatory drugs currently in various trial phases and their possible implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
Ye, Q., Wang, B., & Mao, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.037 · Cited by 2,761
Effective treatment of severe COVID-19 patients with tocilizumab
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,647
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511 · cited 1×
“, blockage of small blood vessels [33,34].”
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science · doi:10.1126/science.abd4570 · Cited by 2,229
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2588-y · Cited by 2,074
Cytokine release syndrome in severe COVID-19
Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912
Coronavirus Disease 2019–COVID-19
Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-20 · Cited by 1,876
Self-citationZhang, C., Wu, Z., Li, J.-W., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758
Shimabukuro-Vornhagen, A., Gödel, P., Subklewe, M., Stemmler, H. J., Schlößer, H. A., Schlaak, M., Kochanek, M., Böll, B., & von Bergwelt-Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,656
McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martínez-Colón, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0944-y · Cited by 1,493
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30304-4 · Cited by 1,456
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,419
The IL-1 family: regulators of immunity
Sims, J. E., & Smith, D. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2691 · Cited by 1,418
Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S.-Y. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.010 · Cited by 1,414
Multiple organ infection and the pathogenesis of SARS
Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305 · cited 2×
“Colony-Stimulating Factor G-CSF, M-CSF, and GM-CSF Hematopoietic growth factors • Activate the different signaling pathways that produce macrophages and granulocytes [78] • Helps sustain the inflammatory reaction”
BackgroundPathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., Qi, Y., Sun, R., Tian, Z., Xu, X., & Wei, H. (2020) · National Science Review · doi:10.1093/nsr/nwaa041 · Cited by 1,295
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Arunachalam, P. S., Wimmers, F., Mok, C. K. P., Perera, R. A. P. M., Scott, M., Hagan, T., Sigal, N., Feng, Y., Bristow, L., Tak-Yin Tsang, O., et al. (2020) · Science · doi:10.1126/science.abc6261 · Cited by 1,186
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., Zhu, Y., Liu, Y., Wang, X., & Wang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25770 · Cited by 1,047
Chua, R. L., Lukassen, S., Trump, S., Hennig, B. P., Wendisch, D., Pott, F., Debnath, O., Thürmann, L., Kurth, F., Völker, M. T., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0602-4 · Cited by 1,035 · cited 3×
“Moreover, clinical features of hyperinflammation, pulmonary damage, and respiratory dysfunction were positively correlated with the overexpression of chemokines and cytokines encoding genes in critically ill patients [48].”
BackgroundInfluential[A pathological report of three COVID-19 cases by minimal invasive autopsies].
Yao, X. H., Li, T. Y., He, Z. C., Ping, Y. F., Liu, H. W., Yu, S. C., Mou, H. M., Wang, L. H., Zhang, H. R., Fu, W. J., et al. (2020) · PubMed · doi:10.3760/cma.j.cn112151-20200312-00193 · Cited by 963
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhou, Z., Ren, L., Zhang, L., Zhong, J., Xiao, Y., Jia, Z., Guo, L., Yang, J., Wang, C., Jiang, S., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.017 · Cited by 938
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Cao, Y., Li, L., Feng, Z., Wan, S., Huang, P., Sun, X., Wen, F., Huang, X., Ning, G., & Wang, W. (2020) · Cell Discovery · doi:10.1038/s41421-020-0147-1 · Cited by 865
COVID-19 with Different Severities: A Multicenter Study of Clinical Features
Feng, Y., Ling, Y., Bai, T., Xie, Y., Huang, J., Li, J., Xiong, W., Yang, D., Chen, R., Lu, F., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0445oc · Cited by 838
Lee, J. S., Park, S., Jeong, H. W., Ahn, J. Y., Choi, S. J., Lee, H., Choi, B., Nam, S. K., Sa, M., Kwon, J.-S., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd1554 · Cited by 825
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
Ding, Y., Wang, H., Shen, H., Li, Z., Geng, J., Han, H., Cai, J., Li, X., Kang, W., Weng, D., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1440 · Cited by 765
Side Effects of Corticosteroid Therapy
Buchman, A. L. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200110000-00006 · Cited by 745
Molecular Evolution of Human Coronavirus Genomes
Forni, D., Cagliani, R., Clerici, M., & Sironi, M. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2016.09.001 · Cited by 739
Parsons, P. E., Eisner, M. D., Thompson, B. T., Matthay, M. A., Ancukiewicz, M., Bernard, G. R., & Wheeler, A. P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000149854.61192.dc · Cited by 723
Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm
Tanaka, T., Narazaki, M., & Kishimoto, T. (2016) · Immunotherapy · doi:10.2217/imt-2016-0020 · Cited by 708
Ramiro, S., Gaujoux-Viala, C., Nam, J. L., Smolen, J. S., Buch, M., Gossec, L., van der Heijde, D., Winthrop, K., & Landewé, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204575 · Cited by 701
[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
Chen, L., Liu, H., Liu, W. Y., Liu, J., Liu, K., Shang, J., Deng, Y., & Wei, S. (2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0005 · Cited by 693
Runfeng, L., Yunlong, H., Jicheng, H., Weiqi, P., Qinhai, M., Yongxia, S., Chufang, L., Jin, Z., Zhenhua, J., Haiming, J., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104761 · Cited by 660
Jamilloux, Y., Henry, T., Belot, A., Viel, S., Fauter, M., El Jammal, T., Walzer, T., François, B., & Sève, P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102567 · Cited by 658
Yang, L., Han, Y., Nilsson-Payant, B. E., Gupta, V., Wang, P., Duan, X., Tang, X., Zhu, J., Zhao, Z., Jaffré, F., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.06.015 · Cited by 642
Genetic Variants of SARS-CoV-2—What Do They Mean?
Lauring, A. S., & Hodcroft, E. B. (2021) · JAMA · doi:10.1001/jama.2020.27124 · Cited by 604
Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19
Qu, R., Ling, Y., Zhang, Y., Wei, L., Chen, X., Li, X., Liu, X., Liu, H., Guo, Z., Ren, H., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25767 · Cited by 580
Kotliar, D., Veres, A., Nagy, M. A., Tabrizi, S., Hodis, E., Melton, D. A., & Sabeti, P. C. (2019) · eLife · doi:10.7554/elife.43803 · Cited by 563
Wan, S., Yi, Q., Fan, S., Lv, J., Zhang, X., Guo, L., Lang, C., Xiao, Q., Xiao, K., Yi, Z., et al. (2020) · doi:10.1101/2020.02.10.20021832 · Cited by 562
Cytokine storm induced by SARS-CoV-2
Song, P., Li, W., Xie, J., Hou, Y., & You, C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.017 · Cited by 537
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Feldmann, M., Maini, R. N., Woody, J. N., Holgate, S. T., Winter, G., Rowland, M., Richards, D., & Hussell, T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30858-8 · Cited by 536
Haga, S., Yamamoto, N., Nakai-Murakami, C., Osawa, Y., Tokunaga, K., Sata, T., Yamamoto, N., Sasazuki, T., & Ishizaka, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711241105 · Cited by 521
Immunopathology of Hyperinflammation in COVID-19
Gustine, J. N., & Jones, D. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.08.009 · Cited by 516
Cytokine storm intervention in the early stages of COVID-19 pneumonia
Sun, X., Wang, T., Cai, D., Hu, Z., Chen, J., Liao, H., Zhi, L., Wei, H., Zhang, Z., Qiu, Y., et al. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.04.002 · Cited by 513 · cited 1×
“organs and tissues, even in the presence of a strong suppressing response of the immune system [43].”
BackgroundConvalescent plasma in Covid-19: Possible mechanisms of action
Rojas, M., Rodríguez, Y., Monsalve, D. M., Acosta-Ampudia, Y., Camacho, B., Gallo, J. E., Rojas-Villarraga, A., Ramírez-Santana, C., Díaz-Coronado, J. C., Manrique, R., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102554 · Cited by 491
An immune-cell signature of bacterial sepsis
Reyes, M., Filbin, M. R., Bhattacharyya, R. P., Billman, K., Eisenhaure, T., Hung, D. T., Levy, B. D., Baron, R. M., Blainey, P. C., Goldberg, M. B., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0752-4 · Cited by 489
COVID-19 and the liver: little cause for concern
Bangash, M. N., Patel, J., & Parekh, D. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30084-4 · Cited by 481
COVID-19 cytokine storm: the anger of inflammation
Mahmudpour, M., Roozbeh, J., Keshavarz, M., Farrokhi, S., & Nabipour, I. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155151 · Cited by 461
Kaplon, H., Muralidharan, M., Schneider, Z., & Reichert, J. M. (2020) · mAbs · doi:10.1080/19420862.2019.1703531 · Cited by 429
Lew, T. W. K. (2003) · JAMA · doi:10.1001/jama.290.3.374 · Cited by 426
Cao, W., Liu, X., Bai, T., Fan, H., Hong, K., Song, H., Han, Y., Lin, L., Ruan, L., & Li, T. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa102 · Cited by 405
Chloroquine and hydroxychloroquine in covid-19
Ferner, R. E., & Aronson, J. K. (2020) · BMJ · doi:10.1136/bmj.m1432 · Cited by 403
Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
Schulert, G. S., & Grom, A. A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-061813-012806 · Cited by 402
Ward, S. G., Bacon, K., & Westwick, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80583-x · Cited by 396
Interferons and viral infections
Fensterl, V., & Sen, G. C. (2009) · BioFactors · doi:10.1002/biof.6 · Cited by 396
COVID-19 and stroke—A global World Stroke Organization perspective
Markus, H. S., & Brainin, M. (2020) · International Journal of Stroke · doi:10.1177/1747493020923472 · Cited by 392
Drosten, C., Seilmaier, M., Corman, V. M., Hartmann, W., Scheible, G., Sack, S., Guggemos, W., Kallies, R., Muth, D., Junglen, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70154-3 · Cited by 387
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Fara, A., Mitrev, Z., Rosalia, R. A., & Assas, B. M. (2020) · Open Biology · doi:10.1098/rsob.200160 · Cited by 369
Evolutionary divergence and functions of the human interleukin (IL) gene family
Brocker, C., Thompson, D., Matsumoto, A., Nebert, D. W., & Vasiliou, V. (2010) · Human Genomics · doi:10.1186/1479-7364-5-1-30 · Cited by 368
Min, C.-K., Cheon, S., Ha, N.-Y., Sohn, K. M., Kim, Y., Aigerim, A., Shin, H. M., Choi, J.-Y., Inn, K.-S., Kim, J.-H., et al. (2016) · Scientific Reports · doi:10.1038/srep25359 · Cited by 364
Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock
Pathan, N., Hemingway, C. A., Alizadeh, A. A., Stephens, A. C., Boldrick, J. C., Oragui, E. E., McCabe, C., Welch, S. B., Whitney, A., O'Gara, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15326-3 · Cited by 362
Chi, Y., Ge, Y., Wu, B., Zhang, W., Wu, T., Wen, T., Liu, J., Guo, X., Huang, C., Jiao, Y., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa363 · Cited by 360
Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates
Smits, S. L., de Lang, A., van den Brand, J. M. A., Leijten, L. M., van IJcken, W. F., Eijkemans, M. J. C., van Amerongen, G., Kuiken, T., Andeweg, A. C., Osterhaus, A. D. M. E., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000756 · Cited by 335
Sheppard, M., Laskou, F., Stapleton, P. P., Hadavi, S., & Dasgupta, B. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1316909 · Cited by 318
The Novel Coronavirus: A Bird's Eye View
Habibzadeh, P., & Stoneman, E. K. (2020) · The International Journal of Occupational and Environmental Medicine · doi:10.15171/ijoem.2020.1921 · Cited by 307
Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome
Reghunathan, R., Jayapal, M., Hsu, L.-Y., Chng, H.-H., Tai, D., Leung, B. P., & Melendez, A. J. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-2 · Cited by 300
IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
Chen, Y., Wang, J., Liu, C., Su, L., Zhang, D., Fan, J., Yang, Y., Xiao, M., Xie, J., Xu, Y., et al. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00230-x · Cited by 297
Pharmaco-Immunomodulatory Therapy in COVID-19
Rizk, J. G., Kalantar-Zadeh, K., Mehra, M. R., Lavie, C. J., Rizk, Y., & Forthal, D. N. (2020) · Drugs · doi:10.1007/s40265-020-01367-z · Cited by 288
Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology
Hussell, T., Pennycook, A., & Openshaw, P. J. M. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200109)31:9<2566::aid-immu2566>3.0.co;2-l · Cited by 283
Sepriano, A., Kerschbaumer, A., Smolen, J. S., van der Heijde, D., Dougados, M., van Vollenhoven, R., McInnes, I. B., Bijlsma, J. W., Burmester, G. R., de Wit, M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216653 · Cited by 275
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
Misra, D. P., Agarwal, V., Gasparyan, A. Y., & Zimba, O. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05073-9 · Cited by 271
Averting inflammation by targeting the cytokine environment
Kopf, M., Bachmann, M. F., & Marsland, B. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2805 · Cited by 257
Role of Chemokines in Endocrine Autoimmune Diseases
Rotondi, M., Chiovato, L., Romagnani, S., Serio, M., & Romagnani, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0044 · Cited by 257
Chemokine and chemotactic signals in dendritic cell migration
Tiberio, L., Del Prete, A., Schioppa, T., Sozio, F., Bosisio, D., & Sozzani, S. (2018) · Cellular & Molecular Immunology · doi:10.1038/s41423-018-0005-3 · Cited by 256
Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure
Epelman, S., Tang, W. H. W., Chen, S. Y., Van Lente, F., Francis, G. S., & Sen, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.088 · Cited by 250
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Ferrara, J. L., Abhyankar, S., & Gilliland, D. G. (1993) · PubMed · Cited by 249
A community approach to mortality prediction in sepsis via gene expression analysis
Sweeney, T. E., Perumal, T. M., Henao, R., Nichols, M., Howrylak, J. A., Choi, A. M., Bermejo-Martin, J. F., Almansa, R., Tamayo, E., Davenport, E. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03078-2 · Cited by 237
The immunology of COVID-19: is immune modulation an option for treatment?
Zhong, J., Tang, J., Ye, C., & Dong, L. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30120-x · Cited by 236
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology
Jiao, X., Nawab, O., Patel, T., Kossenkov, A. V., Halama, N., Jaeger, D., & Pestell, R. G. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1167 · Cited by 232
CHIEN, J., HSUEH, P., CHENG, W., YU, C., & YANG, P. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00942.x · Cited by 225
Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection
Teijaro, J. R., Walsh, K. B., Rice, S., Rosen, H., & Oldstone, M. B. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400593111 · Cited by 222
Marchingo, J. M., Sinclair, L. V., Howden, A. J., & Cantrell, D. A. (2020) · eLife · doi:10.7554/elife.53725 · Cited by 207
COVID-19 and emerging viral infections: The case for interferon lambda
Prokunina-Olsson, L., Alphonse, N., Dickenson, R. E., Durbin, J. E., Glenn, J. S., Hartmann, R., Kotenko, S. V., Lazear, H. M., O’Brien, T. R., Odendall, C., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200653 · Cited by 204
Cytokine storm syndrome in coronavirus disease 2019: A narrative review
Gao, Y. ‐., Xu, G., Wang, B., & Liu, B. ‐. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13144 · Cited by 202
Toll-like receptor 4 in acute viral infection: Too much of a good thing
Olejnik, J., Hume, A. J., & Mühlberger, E. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007390 · Cited by 200
Brisse, E., Wouters, C. H., & Matthys, P. (2016) · British Journal of Haematology · doi:10.1111/bjh.14147 · Cited by 197
Dhama, K., Patel, S. K., Pathak, M., Yatoo, M. I., Tiwari, R., Malik, Y. S., Singh, R., Sah, R., Rabaan, A. A., Bonilla-Aldana, D. K., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101755 · Cited by 192
Self-citationZhang, X., Zhang, Y., Qiao, W., Zhang, J., & Qi, Z. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106749 · Cited by 182
Rabaan, A. A., Al-Ahmed, S. H., Sah, R., Tiwari, R., Yatoo, M. I., Patel, S. K., Pathak, M., Malik, Y. S., Dhama, K., Singh, K. P., et al. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-00384-w · Cited by 177
Self-citationRockx, B., Baas, T., Zornetzer, G. A., Haagmans, B., Sheahan, T., Frieman, M., Dyer, M. D., Teal, T. H., Proll, S., van den Brand, J., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00127-09 · Cited by 176
Filbin, M. R., Lynch, J., Gillingham, T. D., Thorsen, J. E., Pasakarnis, C. L., Nepal, S., Matsushima, M., Rhee, C., Heldt, T., & Reisner, A. T. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003260 · Cited by 167
Walters, T. E., Kalman, J. M., Patel, S. K., Mearns, M., Velkoska, E., & Burrell, L. M. (2016) · Europace · doi:10.1093/europace/euw246 · Cited by 162
Novel RAAS agonists and antagonists: clinical applications and controversies
Romero, C. A., Orías, M., & Weir, M. R. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.6 · Cited by 150
Mesenchymal stem cells and management of COVID-19 pneumonia
Metcalfe, S. M. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100019 · Cited by 150
Coperchini, F., Chiovato, L., Ricci, G., Croce, L., Magri, F., & Rotondi, M. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.12.005 · Cited by 144
Douda, D. N., Jackson, R., Grasemann, H., & Palaniyar, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004201 · Cited by 132
Mahmud, S., Uddin, M. A. R., Paul, G. K., Shimu, M. S. S., Islam, S., Rahman, M. E., Islam, A., Islam, M. S., Promi, M. M., Emran, T. B., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa428 · Cited by 128
Self-citationChemokines in health and disease
Gangur, V., Birmingham, N., & Thanesvorakul, S. (2002) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(02)00018-1 · Cited by 127
Pros and cons of corticosteroid therapy for COVID-19 patients
Mattos-Silva, P., Felix, N. S., Silva, P. L., Robba, C., Battaglini, D., Pelosi, P. P., Rocco, P. R. M., & Cruz, F. F. (2020) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2020.103492 · Cited by 126
The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease
Pasrija, R., & Naime, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107225 · Cited by 120
Fathi, M., Vakili, K. G., Sayehmiri, F., Mohamadkhani, A., Hajiesmaeili, M., Rezaei–Tavirani, M., & Eilami, O. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246190 · Cited by 120
Sharun, K., Tiwari, R., Natesan, S., & Dhama, K. (2020) · Veterinary Quarterly · doi:10.1080/01652176.2020.1867776 · Cited by 115
Self-citationRakib, A., Sami, S. A., Mimi, N. J., Chowdhury, M. M., Eva, T. A., Nainu, F., Paul, A., Shahriar, A., Tareq, A. M., Emon, N. U., et al. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.103967 · Cited by 100
Self-citationFriedman, R. M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03055.x · Cited by 98
Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment
Yeleswaram, S., Smith, P. A., Burn, T. C., Covington, M. B., Juvekar, A., Li, Y., Squier, P., & Langmuir, P. B. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108517 · Cited by 97
Rakib, A., Paul, A., Chy, M. N. U., Sami, S. A., Baral, S. K., Majumder, M., Tareq, A. M., Amin, M. N., Shahriar, A., Uddin, M. Z., et al. (2020) · Molecules · doi:10.3390/molecules25173936 · Cited by 96
Self-citationChowdhury, K. H., Chowdhury, M. R., Mahmud, S., Tareq, A. M., Hanif, N. B., Banu, N., Reza, A. S. M. A., Emran, T. B., & Simal‐Gándara, J. (2020) · Biology · doi:10.3390/biology10010002 · Cited by 95
Self-citationCytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
Pum, A., Ennemoser, M., Adage, T., & Kungl, A. J. (2021) · Biomolecules · doi:10.3390/biom11010091 · Cited by 95
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
Khosroshahi, L. M., Rokni, M., Mokhtari, T., & Noorbakhsh, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107364 · Cited by 94
Keam, S., Megawati, D., Patel, S. K., Tiwari, R., Dhama, K., & Harapan, H. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2123 · Cited by 92
Self-citationSevere acute respiratory syndrome: clinical and laboratory manifestations.
Lam, C. W. K., Chan, M. H. M., & Wong, C. K. (2004) · PubMed Central · Cited by 91
Mustafa, M. I., Abdelmoneim, A. H., Mahmoud, E. M., & Makhawi, A. M. (2020) · Mediators of Inflammation · doi:10.1155/2020/8198963 · Cited by 82
Mesenchymal stem cells as a potential therapy for COVID-19
Liu, S., Peng, D.-Y., Qiu, H., Yang, K., Fu, Z., & Zou, L. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01678-8 · Cited by 80
Rayman, G. A., Lumb, A. N., Kennon, B., Cottrell, C., Nagi, D. K., Page, E., Voigt, D., Courtney, H., Atkins, H., Higgins, K., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14378 · Cited by 79
Sharun, K., Tiwari, R., Yatoo, M. I., Patel, S. K., Natesan, S. K. A., Dhama, J., Malik, Y. S., Harapan, H., Singh, R. K., & Dhama, K. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1796963 · Cited by 79
Self-citationRakib, A., Nain, Z., Sami, S. A., Mahmud, S., Islam, M. A., Ahmed, S., Siddiqui, A. B. F., Babu, S. M. O. F., Hossain, P., Shahriar, A., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab045 · Cited by 79
Self-citationDexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
Sharun, K., Tiwari, R., Dhama, J., & Dhama, K. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.08.038 · Cited by 75
Self-citationPreventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
Lu, L., Zhang, H., Zhan, M., Jiang, J., Yin, H., Dauphars, D. J., Li, S.-Y., Li, Y., & He, Y.-W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00677 · Cited by 72
Baricitinib for COVID-19: a suitable treatment? – Authors' reply
Richardson, P. J., Corbellino, M., & Stebbing, J. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30270-x · Cited by 71
Role of chemokine receptors in thyroid cancer and immunotherapy
Coperchini, F., Croce, L., Marinò, M., Chiovato, L., & Rotondi, M. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0163 · Cited by 59
Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action
Sadeghi, S., Soudi, S., Shafiee, A., & Hashemi, S. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118493 · Cited by 57
Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
Haeberle, H. A., Magunia, H., Lang, P., Gloeckner, H., Körner, A., Koeppen, M., Backchoul, T., Malek, N. P., Handgretinger, R., Rosenberger, P., et al. (2021) · Journal of Intensive Care Medicine · doi:10.1177/0885066621997365 · Cited by 56
Pulmonary Macrophage and Dendritic Cell Responses to Cryptococcus neoformans
Nelson, B. N., Hawkins, A. N., & Wozniak, K. L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00037 · Cited by 53
Capochiani, E., Frediani, B., Iervasi, G., Paolicchi, A., Sani, S., Roncucci, P., Cuccaro, A., Franchi, F., Simonetti, F., Carrara, D., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00466 · Cited by 53
Iannone, L. F., Bennardo, L., Palleria, C., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241575 · Cited by 52
Sharun, K., Tiwari, R., Patel, S. K., Karthik, K., Yatoo, M. I., Malik, Y. S., Singh, K. P., Panwar, P. K., Harapan, H., Singh, R. K., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1807802 · Cited by 51
Self-citationA comprehensive review on potential therapeutics interventions for COVID-19
Chugh, H., Awasthi, A., Agarwal, Y., Gaur, R. K., Dhawan, G., & Chandra, R. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173741 · Cited by 51
He, S., Han, J., & Lichtfouse, É. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01140-4 · Cited by 51
Rakib, A., Sami, S. A., Islam, M. A., Ahmed, S., Faiz, F. B., Khanam, B. H., Marma, K. K. S., Rahman, M., Uddin, M. M. N., Nainu, F., et al. (2020) · Molecules · doi:10.3390/molecules25215088 · Cited by 50
Self-citationThe need for neurologists in the care of COVID‐19 patients
Sellner, J., Taba, P., Öztürk, Ş., & Helbok, R. (2020) · European Journal of Neurology · doi:10.1111/ene.14257 · Cited by 49
COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes
Anand, A. V., Sangeetha, T., Fathah, Z., Pavithra, R., Sanjeev, A. M. A., Babu, S., Meyyazhagan, A., Yatoo, M. I., Sharun, K., Tiwari, R., et al. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.3.01 · Cited by 49
Self-citationGasparello, J., Finotti, A., & Gambari, R. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110415 · Cited by 48
Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2
Wen, F., Yu, H., Guo, J., Li, Y., Luo, K., & Huang, S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.027 · Cited by 46
Corticosteroids in severe COVID-19: a critical view of the evidence
Backer, D. D., Azoulay, É., & Vincent, J. (2020) · Critical Care · doi:10.1186/s13054-020-03360-0 · Cited by 45
Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19
Jeyaraman, M., John, A. A., Koshy, S. K. G., Ranjan, R., Anudeep, T. C., Jain, R., Swati, K., Jha, N. K., Sharma, A., Kesari, K. K., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166014 · Cited by 41
Traditional Chinese herbal medicine-potential therapeutic application for the treatment of COVID-19
Capodice, J. L., & Chubak, B. M. (2021) · Chinese Medicine · doi:10.1186/s13020-020-00419-6 · Cited by 41
Immunotherapies and immunomodulatory approaches in clinical trials - a mini review
Yatoo, M. I., Hamid, Z., RATHER, I. A., Nazir, Q. U. A., Bhat, R. A., Haq, A. U., Magray, S. N., Haq, Z. U., Sah, R., Tiwari, R., et al. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1871295 · Cited by 38
Self-citationNguyen, L. S., Hamou, Z. A., Gastli, N., Chapuis, N., & Pène, F. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06377-3 · Cited by 37
Medicinal and therapeutic potential of withanolides from Withania somnifera against COVID-19
Dhawan, M. K., Manisha, P., Sharun, K., Tiwari, R., Bilal, M., & Dhama, K. (2021) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2021.110402 · Cited by 35
Self-citationPromising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm
Peng, X., Wang, Y., Xi, X., Jia, Y., Tian, J., Yu, B., & Tian, J. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07120-8 · Cited by 34
BCG vaccine: a hope to control COVID-19 pandemic amid crisis
Malik, Y. S., Ansari, M. I., Ganesh, B., Sircar, S., Bhat, S., Pande, T., Vinodhkumar, O. R., Kumar, P., Yatoo, M. I., Tiwari, R., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1818522 · Cited by 32
Self-citationMoradimajd, P., Samaee, H., Maroufi, S. S., Kourosh‐Arami, M., & Mohsenzadegan, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26727 · Cited by 32
Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
Xi, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00310-8 · Cited by 31
Kupani, M., Pandey, R. K., & Mehrotra, S. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30029 · Cited by 31
Pottoo, F. H., Abu‐Izneid, T., Ibrahim, A. M., Javed, M. N., Alhajri, N., & Hamrouni, A. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.12.018 · Cited by 30
Clinical evidence of an interferon–glucocorticoid therapeutic synergy in COVID-19
Lü, Y., Liu, F., Tong, G., Qiu, F., Song, P., Wang, X., Zou, X., Wan, D., Cui, M., Xu, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00496-5 · Cited by 30
Ebrahimi, N., Aslani, S., Babaie, F., Hemmatzadeh, M., Hosseinzadeh, R., Joneidi, Z., Tourzani, Z. M., Pakravan, N., & Mohammadi, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107082 · Cited by 29
The Search for Efficacious New Therapies in Sepsis Needs to Embrace Heterogeneity
Scicluna, B. P., & Baillie, J. K. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201811-2148ed · Cited by 28
Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2
Sajna, K. V., & Kamat, S. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2020.08.009 · Cited by 23
Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19
Xiong, J., Chen, L., Zhang, L., Bao, L., & Shi, Y. (2021) · Cell Transplantation · doi:10.1177/0963689721995455 · Cited by 19
Shi, M.-Y., Sun, S.-Q., Zhang, W., Zhang, X., Xu, G.-H., Chen, X., Su, Z.-J., Song, X.-M., Liu, L.-J., Zhang, Y.-B., et al. (2021) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2021.01.002 · Cited by 18
Rockx, B., Baas, T., Zornetzer, G. A., Haagmans, B. L., Sheahan, T. P., Frieman, M. B., Dyer, M. D., Teal, T. H., Proll, S. C., van den Brand, J. M. A., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01322-09 · Cited by 14
Herbal Medication to Enhance or Modulate Viral Infections
Tahmasbi, S. F., Revell, M. A., & Tahmasebi, N. (2020) · Nursing Clinics of North America · doi:10.1016/j.cnur.2020.10.007 · Cited by 14
Repurposing antivirals as potential treatments for SARS-CoV-2: From SARS to COVID-19
Gómez-Ríos, D., López-Agudelo, V. A., & Ramírez-Malule, H. (2020) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2020.10501 · Cited by 14
COVID-19: benefits and risks of passive immunotherapeutics
Gupta, A., Karki, R., Dandu, H. R., Dhama, K., Bhatt, M. L., & Saxena, S. K. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1808410 · Cited by 11
Self-citationTargeting mesenchymal stem cell therapy for severe pneumonia patients
Lam, G., Zhou, Y., Wang, J., & Tsui, Y.-P. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i2.139 · Cited by 8
ROLE OF TOLL-LIKE RECEPTORS IN CORONAVIRUS INFECTION AND IMMUNE RESPONSE
Iqbal, M. S., Sardar, N., Akmal, W., Sultan, R., Abdullah, H., Qindeel, M., Dhama, K., & Bilal, M. (2020) · Journal of Experimental Biology and Agricultural Sciences · doi:10.18006/2020.8(spl-1-sars-cov-2).s66.s78 · Cited by 7
Self-citationIqbal, M., Sardar, N., Akmal, W., Qadri, A., Nawaz, R., Miraj, A., Akram, A., Manzoor, Y., Bilal, M., & Khan, M. I. (2020) · Journal of Experimental Biology and Agricultural Sciences · doi:10.18006/2020.8(spl-1-sars-cov-2).s87.s102 · Cited by 5
Self-citationQamar, S. A., Basharat, K., Bilal, M., & Iqbal, H. M. N. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.3.08 · Cited by 4
Self-citationSepsis and septic shock in COVID-19: a scoping review of the research dataPreprint
Lakoh, S., Jiba, D. F., Baldeh, M., Vandy, A. O., Benya, H., Lado, M., Sevalie, S., Yendewa, G. A., & Sahr, F. (2020) · doi:10.21203/rs.3.rs-30474/v1 · Cited by 4
Bilal, M., Sarfaraz, M. I., Husnain, M., Sardar, N., Akmal, W., Sultan, R., & Qamar, S. A. (2020) · Journal of Experimental Biology and Agricultural Sciences · doi:10.18006/2020.8(spl-1-sars-cov-2).s190.s201 · Cited by 1
Self-citation
Cited by
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
D’Agnillo, F., Walters, K.-A., Xiao, Y., Sheng, Z.-M., Scherler, K., Park, J., Gygli, S., Rosas, L. A., Sadtler, K., Kalish, H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj7790 · Cited by 237
Metadata
- Authors
- Rabaan, A. A., Al-Ahmed, S. H., Muhammad, J., Khan, A., Sule, A. A., Tirupathi, R., Mutair, A. A., Alhumaid, S., Al-Omari, A., Dhawan, M., Tiwari, R., Sharun, K., Mohapatra, R. K., Mitra, S., Bilal, M., Alyami, S. A., Emran, T. B., Moni, M. A., & Dhama, K.
- Venue
- Vaccines
- Publisher
- MDPI AG
- Published
- 2021-04-29
- Volume
- 9
- Issue
- 5
- Pages
- 436
- ISSN
- 2076-393X (ISSN-L)
- OpenAlex
- W3157597190
- Cited by
- 255
- References
- 179
- FWCI
- 15.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.